OTLK · Outlook Therapeutics, Inc. · Analyst Estimates
$0.59
+0.02 (+3.13%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because our cash and cash equivalents, together with $51.1 million of net proceeds from our August 2026 Offering, will not be adequate to fund our currently planned operations through at least the 12 months from the date of this Quarterly Report, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 18, 2026
Market Cap
$155.68M
Shares
243.45M
Volume · Oct 2
5.62M
Avg daily vol (3M)
13.63M
Analyst Estimates
Compare analyst forecasts for Outlook Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 16:38 UTC · Publication dates shown per estimate · 16 metric / period groups
FY ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.45
|
-0.435
|
-0.42
|
— |
-0.49333
|
-0.51
|
-0.42
|
-0.51
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
2
|
— | — | — | — |
0
|
0
|
0
|
1
|
|
Revenue
USD
Publication date not stated |
-100000
|
682670
|
1748000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |
FY ending 2027-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.27
|
-0.12
|
-0.03
|
— |
-0.16
|
-0.22
|
-0.14
|
-0.22
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
0
|
0
|
1
|
0
|
|
Revenue
USD
Publication date not stated |
30000000
|
44070750
|
74742000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.08
|
-0.075
|
-0.07
|
— |
-0.055
|
-0.08
|
-0.06
|
-0.08
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
2
|
— | — | — | — |
0
|
0
|
2
|
0
|
|
Revenue
USD
Publication date not stated |
1500000
|
2159500
|
2819000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
2
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.08
|
-0.04667
|
-0.01
|
— |
-0.05
|
-0.075
|
-0.05
|
-0.075
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
1300000
|
5304750
|
8900000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
4
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1649989
CUSIP
69012T305
13F (30d)
11 filings
3 filers
Visit website
Investor relations